ACCELERATE DIAGNOSTICS, INC. Common Stock (par value $0.001 per share) Equity Sales AgreementEquity Sales Agreement • May 28th, 2021 • Accelerate Diagnostics, Inc • Laboratory analytical instruments • New York
Accelerate Diagnostics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with William Blair & Company, L.L.C. (the “Agent”) as follows:
